GH
Greg Harrison B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$18.3B
| $403.80 | $463 |
15%
upside
| Neutral |
2 Sep ‘25
7 days ago |
|
2
Mineralys Therapeutics
MLYS
$2.99B
| $38.50 | $43 |
12%
upside
| Buy |
28 Aug ‘25
12 days ago |
|
3
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $31 |
43%
upside
| Sector Outperform |
7 Aug ‘25
1 month ago |
|
4
Ocular Therapeutix
OCUL
$2.21B
| $12.76 | $20 |
57%
upside
| Sector Outperform |
6 Aug ‘25
1 month ago |
|
5
BridgeBio Pharma
BBIO
$10.4B
| $53.50 | $57 |
7%
upside
| Sector Outperform |
6 Aug ‘25
1 month ago |
|
6
Vertex Pharmaceuticals
VRTX
$101B
| $396.48 | $438 |
10%
upside
| Sector Perform |
5 Aug ‘25
1 month ago |
|
7
Alnylam Pharmaceuticals
ALNY
$63.2B
| $482.13 | $450 |
7%
downside
| Sector Outperform |
1 Aug ‘25
1 month ago |
|
8
Agios Pharmaceuticals
AGIO
$2.1B
| $36.15 | $65 |
80%
upside
| Sector Outperform |
28 Jul ‘25
1 month ago |
|
9
Rocket Pharmaceuticals
RCKT
$346M
| $3.21 | $4 |
25%
upside
| Neutral |
25 Jul ‘25
1 month ago |
|
|
10
Agios Pharmaceuticals
AGIO
$2.1B
| $36.15 | $51 |
41%
upside
| Buy |
22 Jul ‘25
1 month ago |
|
11
Gossamer Bio
GOSS
$630M
| $2.77 | $11 |
297%
upside
| Sector Outperform |
14 Jul ‘25
1 month ago |
|
12
Arcturus Therapeutics
ARCT
$484M
| $17.94 | $35 |
95%
upside
| Sector Outperform |
2 Jul ‘25
2 months ago |
|
13
Vera Therapeutics
VERA
$1.6B
| $25.08 | $55 |
119%
upside
| Sector Outperform |
2 Jun ‘25
3 months ago |
|
|
14
Rocket Pharmaceuticals
RCKT
$346M
| $3.21 | $19 |
492%
upside
| Sector Outperform |
28 May ‘25
3 months ago |
|
15
Liquidia Corp
LQDA
$2.39B
| $27.80 | $37 |
33%
upside
| Sector Outperform |
28 May ‘25
3 months ago |
|
16
Keros Therapeutics
KROS
$628M
| $15.71 | $26 |
66%
upside
| Sector Outperform |
12 May ‘25
4 months ago |
|
17
Apellis Pharmaceuticals
APLS
$3.4B
| $26.84 | $20 |
25%
downside
| Sector Perform |
8 May ‘25
4 months ago |
|
18
Geron
GERN
$868M
| $1.36 | $1.50 |
10%
upside
| Sector Perform |
8 May ‘25
4 months ago |
|
19
Beam Therapeutics
BEAM
$2.06B
| $20.36 | $40 |
96%
upside
| Sector Outperform |
10 Mar ‘25
6 months ago |
|
20
Disc Medicine
IRON
$2.15B
| $60.34 | $75 |
24%
upside
| Sector Outperform |
3 Mar ‘25
6 months ago |
|
|
21
Keros Therapeutics
KROS
$628M
| $15.71 | $77 |
390%
upside
| Buy |
3 Dec ‘24
9 months ago |
|
22
EyePoint Pharmaceuticals
EYPT
$941M
| $14.19 | $18 |
27%
upside
| Sector Outperform |
16 Oct ‘24
10 months ago |
|
|
23
Liquidia Corp
LQDA
$2.39B
| $27.80 | $15 |
46%
downside
| Buy |
21 Dec ‘23
1 year ago |
|
|
24
Beam Therapeutics
BEAM
$2.06B
| $20.36 | $35 |
72%
upside
| Neutral |
15 Dec ‘23
1 year ago |
|
|
25
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $27 |
25%
upside
| Buy |
22 Sep ‘23
1 year ago |
|